Biotheranostics stock
WebJan 8, 2024 · Hologic, Inc. (. HOLX Quick Quote. HOLX - Free Report) recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company … WebFeb 22, 2024 · Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. In …
Biotheranostics stock
Did you know?
WebHeader placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. WebJan 19, 2024 · Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer patients. ... The bank suspended its …
WebDec 11, 2024 · San Diego, CA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., announces the launch of its Not Another Minute campaign, revealing how Breast Cancer Index (BCI) is changing the game for early-stage, hormone receptor-positive (HR+) breast cancer patients. At the 42nd annual San Antonio Breast Cancer Symposium … WebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing …
WebTheranos Inc. (/ ˈ θ ɛr. ə n. oʊ s /) was an American privately held corporation that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014. The … WebJan 6, 2024 · Ana Baraulia - stock.adobe.com. The Marlborough, MA-based company said it would acquire Biotheranostics for $230 million. Omar Ford Jan 06, 2024. ... Biotheranostics generated about $33 …
WebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It offers CancerTYPE ID, a gene expression test for metastatic patients with diagnostic ambiguity, and Breast Cancer Index, a tool for breast cancer patients.
WebJan 5, 2024 · SPX. +1.87%. Medical technology company Hologic Inc. HOLX, +0.71% said late Tuesday it has agreed to buy privately held Biotheranostics Inc. for $230 million. Biotheranostics, which generated ... cif cash\\u0026carryWebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial … cif cash basauriWebJan 19, 2024 · Contact Data Lisa Whitmyer Biotheranostics, Inc. 216-513-7808 [email protected] dharc official siteWebJan 5, 2024 · Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the company has set the foundation … dharawal words phrases and activitiesWebApr 19, 2024 · The United States alleged that Biotheranostics Inc. — a diagnostic laboratory testing company — knowingly promoted and performed the Breast Cancer Index test for breast cancer patients who … dh architecture and designWebFeb 21, 2024 · This report contains market sizing and forecasts for this important area of molecular testing, including the following global market information: Global Molecular Cancer Diagnostics Market, 2024 ... dharawal word for whaleWebLucile ; Healios, Ryne Bio . IC, IC : Program Committee, Speaker Agudo . Judith : No Relationships . Speaker . Ahn Jiyoung No Relationships Speaker c if case